The new pill, called AD109, is a combination of atomoxetine and aroxybutynin, two drugs that tell your brain to keep the ...

Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

If you don't like the high prices that can come with popular weight-loss drugs like Ozempic-or the needle pokes they ...

A new scientific study has found that weight loss jabs such as Mounjaro and Ozempic can help protect against serious health ...

Results from this study show that there is a direct correlation between the use of anti-obesity medications and testosterone levels,” the study author said.

A new weekly injection may soon transform how millions manage Parkinson’s disease. For over 8.5 million people living with ...

Changes in eating habits are impacting some categories, like snacks, more than others. Taking GLP-1 drugs reduces a person's ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there? Here's what to know.

Research shows morning workouts may be optimal for weight loss and mental health, though experts stress that quality sleep remains essential for exercise effectiveness.